A Novel Immunobiotics Bacteroides dorei Ameliorates Influenza Virus Infection in Mice

ObjectiveProbiotics can modulate immune responses to resist influenza infection. This study aims to evaluate the anti-viral efficacy of B. dorei.MethodsC57BL/6J mice were infected with influenza virus together with treatment of PBS vehicle, B. dorei, or oseltamivir respectively. Anti-influenza poten...

Full description

Bibliographic Details
Main Authors: Liqiong Song, Yuanming Huang, Guoxing Liu, Xianping Li, Yuchun Xiao, Chang Liu, Yue Zhang, Jintong Li, Jianguo Xu, Shan Lu, Zhihong Ren
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.828887/full
_version_ 1798025010042896384
author Liqiong Song
Yuanming Huang
Guoxing Liu
Guoxing Liu
Xianping Li
Yuchun Xiao
Chang Liu
Yue Zhang
Jintong Li
Jianguo Xu
Shan Lu
Zhihong Ren
author_facet Liqiong Song
Yuanming Huang
Guoxing Liu
Guoxing Liu
Xianping Li
Yuchun Xiao
Chang Liu
Yue Zhang
Jintong Li
Jianguo Xu
Shan Lu
Zhihong Ren
author_sort Liqiong Song
collection DOAJ
description ObjectiveProbiotics can modulate immune responses to resist influenza infection. This study aims to evaluate the anti-viral efficacy of B. dorei.MethodsC57BL/6J mice were infected with influenza virus together with treatment of PBS vehicle, B. dorei, or oseltamivir respectively. Anti-influenza potency of B. dorei and the underlying mechanism were determined by measuring survival rate, lung viral load and pathology, gene expression and production of cytokines and chemokines, and analysis of gut microbiota.ResultsAdministration of B. dorei increased (by 30%) the survival of influenza-infected mice, and improved their weight loss, lung pathology, lung index, and colon length compared to the vehicle control group. B. dorei treatment reduced (by 61%) the viral load of lung tissue and increased expression of type 1 interferon more rapidly at day 3 postinfection. At day 7 postinfection, B. dorei-treated mice showed lower local (lung) and systemic (serum) levels of interferon and several proinflammatory cytokines or chemokines (IL-1β, IL-6, TNF-α, IL-10, MCP-1 and IP-10) with a efficacy comparable to oseltamivi treatment. B. dorei treatment also altered gut microbiota as indicated by increased levels of Bacteroides, Prevotella, and Lactobacillus and decreased levels of Escherichia, Shigella, and Parabacteroides.ConclusionB. dorei has anti-influenza effect. Its working mechanisms involve promoting earlier interferon expression and down-regulating both local and systemic inflammatory response. B. dorei changes the composition of gut microbiota, which may also contribute to its beneficial effects.
first_indexed 2024-04-11T18:11:51Z
format Article
id doaj.art-6669704c8c454dcab08f1410491a6b9c
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-11T18:11:51Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-6669704c8c454dcab08f1410491a6b9c2022-12-22T04:10:06ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-01-011210.3389/fimmu.2021.828887828887A Novel Immunobiotics Bacteroides dorei Ameliorates Influenza Virus Infection in MiceLiqiong Song0Yuanming Huang1Guoxing Liu2Guoxing Liu3Xianping Li4Yuchun Xiao5Chang Liu6Yue Zhang7Jintong Li8Jianguo Xu9Shan Lu10Zhihong Ren11State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Research Units of Discovery of Unknown Bacteria and Function (2018 RU010), Chinese Academy of Medical Sciences, Beijing, ChinaState Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Research Units of Discovery of Unknown Bacteria and Function (2018 RU010), Chinese Academy of Medical Sciences, Beijing, ChinaRespiratory Department, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, ChinaTraditional Chinese Medicine Department, Linwei Liu Zunji Clinic of Traditional Chinese Medicine, Weinan, ChinaState Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Research Units of Discovery of Unknown Bacteria and Function (2018 RU010), Chinese Academy of Medical Sciences, Beijing, ChinaState Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Research Units of Discovery of Unknown Bacteria and Function (2018 RU010), Chinese Academy of Medical Sciences, Beijing, ChinaRespiratory Department, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, ChinaRespiratory Department, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, ChinaRespiratory Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, ChinaState Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Research Units of Discovery of Unknown Bacteria and Function (2018 RU010), Chinese Academy of Medical Sciences, Beijing, ChinaState Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Research Units of Discovery of Unknown Bacteria and Function (2018 RU010), Chinese Academy of Medical Sciences, Beijing, ChinaState Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Research Units of Discovery of Unknown Bacteria and Function (2018 RU010), Chinese Academy of Medical Sciences, Beijing, ChinaObjectiveProbiotics can modulate immune responses to resist influenza infection. This study aims to evaluate the anti-viral efficacy of B. dorei.MethodsC57BL/6J mice were infected with influenza virus together with treatment of PBS vehicle, B. dorei, or oseltamivir respectively. Anti-influenza potency of B. dorei and the underlying mechanism were determined by measuring survival rate, lung viral load and pathology, gene expression and production of cytokines and chemokines, and analysis of gut microbiota.ResultsAdministration of B. dorei increased (by 30%) the survival of influenza-infected mice, and improved their weight loss, lung pathology, lung index, and colon length compared to the vehicle control group. B. dorei treatment reduced (by 61%) the viral load of lung tissue and increased expression of type 1 interferon more rapidly at day 3 postinfection. At day 7 postinfection, B. dorei-treated mice showed lower local (lung) and systemic (serum) levels of interferon and several proinflammatory cytokines or chemokines (IL-1β, IL-6, TNF-α, IL-10, MCP-1 and IP-10) with a efficacy comparable to oseltamivi treatment. B. dorei treatment also altered gut microbiota as indicated by increased levels of Bacteroides, Prevotella, and Lactobacillus and decreased levels of Escherichia, Shigella, and Parabacteroides.ConclusionB. dorei has anti-influenza effect. Its working mechanisms involve promoting earlier interferon expression and down-regulating both local and systemic inflammatory response. B. dorei changes the composition of gut microbiota, which may also contribute to its beneficial effects.https://www.frontiersin.org/articles/10.3389/fimmu.2021.828887/fullB. doreiinfluenzainterferongut microbiotacytokines
spellingShingle Liqiong Song
Yuanming Huang
Guoxing Liu
Guoxing Liu
Xianping Li
Yuchun Xiao
Chang Liu
Yue Zhang
Jintong Li
Jianguo Xu
Shan Lu
Zhihong Ren
A Novel Immunobiotics Bacteroides dorei Ameliorates Influenza Virus Infection in Mice
Frontiers in Immunology
B. dorei
influenza
interferon
gut microbiota
cytokines
title A Novel Immunobiotics Bacteroides dorei Ameliorates Influenza Virus Infection in Mice
title_full A Novel Immunobiotics Bacteroides dorei Ameliorates Influenza Virus Infection in Mice
title_fullStr A Novel Immunobiotics Bacteroides dorei Ameliorates Influenza Virus Infection in Mice
title_full_unstemmed A Novel Immunobiotics Bacteroides dorei Ameliorates Influenza Virus Infection in Mice
title_short A Novel Immunobiotics Bacteroides dorei Ameliorates Influenza Virus Infection in Mice
title_sort novel immunobiotics bacteroides dorei ameliorates influenza virus infection in mice
topic B. dorei
influenza
interferon
gut microbiota
cytokines
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.828887/full
work_keys_str_mv AT liqiongsong anovelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT yuanminghuang anovelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT guoxingliu anovelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT guoxingliu anovelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT xianpingli anovelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT yuchunxiao anovelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT changliu anovelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT yuezhang anovelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT jintongli anovelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT jianguoxu anovelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT shanlu anovelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT zhihongren anovelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT liqiongsong novelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT yuanminghuang novelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT guoxingliu novelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT guoxingliu novelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT xianpingli novelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT yuchunxiao novelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT changliu novelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT yuezhang novelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT jintongli novelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT jianguoxu novelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT shanlu novelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice
AT zhihongren novelimmunobioticsbacteroidesdoreiamelioratesinfluenzavirusinfectioninmice